About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Chicago | 254 Studies

Clinical Trials Colorectal CancerChicago

Colorectal Cancer Clinical Trials in Chicago

Find 254 clinical trials for colorectal cancer near Chicago, Illinois. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 254 trials

CompletedS1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)This randomized clinical trial studies prophylactic colony stimulating factor management in patients with breast, colorectal or non-small cell lung cancer receiving chemotherapy…NCT02728596·Jonesboro, Arkansas and 159 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedTezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal CancerThe primary purpose of this study is to determine the best dose of tezacitabine when combined with oxaliplatin in patients with metastatic colorectal cancer.NCT00051688·Tucson, Arizona and 7 others

CompletedA Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal CancerThis is a global, randomized, double-blind, placebo-controlled, multicenter phase 3 clinical trial to compare the efficacy and safety of fruquintinib plus best supportive care…NCT04322539·Phoenix, Arizona and 152 others

CompletedTheraSphere for the Treatment of Liver MetastasesThis study will evaluate Liver Progression Free Survival (PFS) and safety of TheraSphere treatment at doses of 120 Gy +/1 10% in patients at least 18 years of age diagnosed with…NCT00511862·Chicago, Illinois and 4 others

Active not recruitingStudy of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesThis study is a first-in-human (FIH), Phase 1/1b, open-label, multicenter dose escalation and dose expansion study to assess the safety, tolerability, pharmacokinetics (PK)…NCT05783622·Duarte, California and 17 others

TerminatedA Study of PY314 in Subjects With Advanced Solid TumorsThis is an open-label, multicenter, first in human, Phase 1a/1b study of PY314 in subjects with locally advanced (unresectable) and/or metastatic solid tumors that are refractory…NCT04691375·Phoenix, Arizona and 22 others

RecruitingA Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerThe main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).NCT06792695·Scottsdale, Arizona and 75 others

CompletedA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersThis is a first-in-human, Phase 1, multicenter, open-label, dose-escalation study to establish the maximum-tolerated dose (MTD) or recommended dosage (RD) of ZW49, the…NCT03821233·Duarte, California and 15 others

Active not recruiting9-ING-41 in Patients With Advanced CancersGSK-3β is a potentially important therapeutic target in human malignancies.NCT03678883·Phoenix, Arizona and 65 others

CompletedThe National CT Colonography TrialRATIONALE: New diagnostic procedures such as computed tomographic colonography may improve the ability to detect colorectal cancer and may provide a less invasive method of…NCT00084929·Scottsdale, Arizona and 13 others

Active not recruitingA Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsThe main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid…NCT06607185·Birmingham, Alabama and 44 others

RecruitingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionThis is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose escalation and expansion study of the safety, pharmacokinetics (PK), pharmacodynamics, and antitumor…NCT06756035·Denver, Colorado and 8 others

TerminatedRosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By SurgeryRATIONALE: Rosuvastatin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT01011478·Anniston, Alabama and 586 others

CompletedRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionThis phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with liver dysfunction.NCT01638533·Duarte, California and 11 others

CompletedQuality Improvement of Patient-Provider Communication For Colorectal Cancer ScreeningThe immediate objective of this proposal is to assess the effectiveness of a multi-faceted intervention to improve patient-provider communication about colorectal cancer screening…NCT00324753·Chicago, Illinois and 2 others

CompletedA Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line TherapyThe objective of this study is to compare the progression free survival (PFS), overall survival (OS), objective response rate (ORR), time to treatment failure (TTF), duration of…NCT01478594·Gilbert, Arizona and 72 others

CompletedFOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal CancerThis study is a randomized, multi-center study that will compare the efficacy and safety of selective internal radiation therapy (SIRT) using SIR-Spheres microspheres plus a…NCT01721954·Duarte, California and 82 others

WithdrawnPedaling at a Low-Moderate Intensity During Chemotherapy AdministrationThe purpose of this study is to evaluate the feasibility of completing a low-moderate intensity pedaling session concurrent to chemotherapy treatment for colorectal cancer.NCT04258969·Chicago, Illinois

CompletedImproving Rates of Repeat Colorectal Cancer ScreeningThe United States Preventive Services Task Force (USPSTF) recommends colorectal cancer (CRC) screening using fecal occult blood testing (FOBT), sigmoidoscopy, or colonoscopy in…NCT01453894·Chicago, Illinois

CompletedCombination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck CancerThe purpose of the study is to determine the safety, tolerability and maximum tolerated dose of Urelumab in combination with Cetuximab in patients with Advanced/Metastatic…NCT02110082·Stanford, California and 6 others

PreviousPage 2 of 13Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma